Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Cann Group ( (AU:CAN) ).
Cann Group Limited has announced the quotation of 4,517,749 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of December 2, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially expand its market presence, reflecting a significant step in its growth and operational strategy.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis. The company is engaged in developing cannabis-based products for therapeutic use, targeting both domestic and international markets.
Average Trading Volume: 3,900,024
Technical Sentiment Signal: Sell
Current Market Cap: A$10.06M
Learn more about CAN stock on TipRanks’ Stock Analysis page.